← All indications
Nutritional and Metabolic Diseases
A collective term for nutritional disorders resulting from poor absorption or nutritional imbalance, and metabolic disorders resulting from defects in biosynthesis (ANABOLISM) or breakdown (CATABOLISM) of endogenous substances.
Subtype terms (2)
More specific conditions that are subtypes of Nutritional and Metabolic Diseases in the MeSH hierarchy.
- Metabolic Diseases
247 drugs (120 approved, 127 experimental)
- Nutrition Disorders
33 drugs (21 approved, 12 experimental)
Drugs by status
Approved for this indication (5)
Phase 4 trials (2)
Phase 3 trials (1)
Phase 2 trials (6)
Phase 1 trials (2)
Other trials (54)
- sucrose
- artichoke
- canola oil
- captafer
- oatmeal
- d-mannose
- dextran
- egg
- calcium
- whey protein
- ketone
- ketosteril
- monosialoganglioside
- honey
- reconvan
- sesame oil
- sunflower oil
- conjugated linoleic acid
- triglycerides
- glucose
- uracil
- strawberry
- arabinoxylan
- coffee
- flax
- goat cheese
- moringa oleifera
- almond
- oligofructose
- palmitic acid
- +24 more